PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
批准号:
3774547
负责人:
Y POMMIER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
DNA拓扑异构酶I和II(top 1和top 2)是癌症的主要靶点
化疗拓扑异构酶毒素通过稳定酶联DNA起作用
可以检测到的断裂是药物中的蛋白质相关DNA断裂,
处理的细胞。该项目的目标是研究药物相互作用,
细胞DNA,并阐明抗肿瘤机制的顶部1和2
毒素和它们对癌细胞的选择性。
我们研究了几种新的拓扑异构酶的细胞效应
抑制剂,包括前2种抑制剂,氮杂毒素(NCI专利)和
羟基柔红霉素,目前在临床试验中的各种前1名抑制剂,
和双重前1和前2抑制剂,intoplicine(在早期临床
欧洲的审判)。 另外,我们有证据表明
在人类中切割位点的分布彼此不同
在安吖啶和依托泊苷的情况下c-myc基因。因此,似乎
前2种抑制剂的优先基因损伤可能有助于其
不同的抗癌活性。
我们和其他人最近将“凋亡”描述为细胞死亡的一种模式,
特别是在暴露于拓扑异构酶的恶性造血细胞中
抑制剂的 有趣的是,HL-60细胞通过凋亡而在间期死亡
而人结肠癌HT-29在药物治疗后3小时内,
细胞和中国仓鼠DC 3F成纤维细胞在24-48小时后因G2阻滞而死亡
小时 我们建立了一个体外试验,
使用分离的细胞核和细胞质提取物进行DNA片段化,
研究了各种方法来刺激(使用蛋白激酶抑制剂,
如星形孢菌素)或抑制HL-60细胞凋亡(精胺,
锌,聚[ADPribose]聚合酶抑制剂)。 细胞凋亡与
癌症化疗,因为它的发生可以解释
白血病对化疗药物和血液学药物过敏
毒性 因此,旨在触发或抑制
凋亡可能提供新的治疗策略,并有助于减少药物副作用
方面的影响.
英文摘要
DNA topoisomerase I and II (top 1 and top 2) are major targets for cancer
chemotherapy. Topoisomerase poisons act by stabilizing enzyme-linked DNA
breaks which can be detected as protein-associated DNA breaks in drug-
treated cells. The goal of this project is to study drug interactions with
cellular DNA and to elucidate the antitumor mechanisms of top 1 and 2
poisons, and their selectivity for cancer cells.
We have studied the cellular effects of several new topoisomerase
inhibitors including the top 2 inhibitors, azatoxin (NCI patent) and
hydroxyrubicin, the various top 1 inhibitors presently in clinical trials,
and the dual top 1 and top 2 inhibitor, intoplicine (in early clinical
trials in Europe). Also, we have obtained evidence that top 2 poisons
differ from each other by the distribution of cleavage sites in the human
c-myc gene in the case of amsacrine and etoposides. Thus, it appears that
preferential gene damage by top 2 inhibitors may contribute to their
differential anti cancer activity.
We and others have recently described "apoptosis" as a mode of cell death,
especially in malignant hematopoietic cells exposed to topoisomerase
inhibitors. Interestingly, HL-60 cells die in interphase by apoptosis
within 3 hours after drug treatment, while human colon carcinoma HT-29
cells and Chinese hamster DC3F fibroblasts die by G2 block after 24-48
hours. We have set up an in vitro assay to reconstitute the nucleosomal
DNA fragmentation using isolated nuclei and cytoplasmic extracts and have
studied various ways to either stimulate (using protein kinase inhibitors,
such as staurosporine) or inhibit apoptosis in HL-60 cells (spermine,
Zinc, poly[ADPribose] polymerase inhibitors). Apoptosis is relevant to
cancer chemotherapy because its occurrence may explain the
hypersensitivity of leukemia to chemotherapy and drug hematological
toxicity. Hence, new approaches aimed at triggering or suppressing
apoptosis may provide new therapeutic strategies and help reduce drug side
effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3916548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3939497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:3838171
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3752315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3853153
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:2463724
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:2463710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3752316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3838030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:2463709
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3874383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3963209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA STRAND BREAKS AS INDICATOR OF TOPOI
-
批准号:4692081
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:4692083
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:6100896
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3774548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:6160983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3916549
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:5201240
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:3774690
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
海外基金